Saisung Corporation Limited.

SAISUNG® Pharmaceuticals is a global division of Saisung Group committed to maintaining the quality of human life by bringing innovative medicines to patients worldwide and the healthcare providers who serve them.

Over 200 medicinal and vaccine products manufactured in GMP/ISO compliant facilities, including: Viral and Bacterial Vaccines, Antitoxins, Blood products, Immunoregulators, Toxoids.

Activity:

- Clinical Trials
- Manufacturing
- Market Research & Marketing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Cosmoceuticals
- Curative
- Diagnostics
- Drug delivery
- Enzymes
- Generics
- FP (finished products)
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Preventive
- Proteins
- Technology

Therapeutic targets:

- AIDS
- Allergy
- Asthma
- Cough / Cold
- Dermatology
- Diabetes
- Epidemiology
- Infectious Diseases
- Mental Health
- Pain
- Reproductive Health
- Stroke
- Surgery
- Women's Health

Markets Covered

a. HeadQuarter: Hong Kong

b. Continent(s) active: Asia , Far East , Near/Middle East , Africa , Central/South America , Europe

c. Countries active: Worldwide

Corporate data:

Number of Employees: >100

Turnover:

Amount:	Year:	Currency:
21.6M	2002	Euro

Year founded: 1989